Articles Tagged With:
-
The Utility of Nuchal Translucency Screening in the Era of Cell-Free Fetal DNA Testing
In this retrospective cohort study of 1,901 pregnant women between 11 weeks and 13 weeks six days of gestation who had a nuchal translucency (NT) screening for fetal aneuploidies and demonstrated NT measurements > 95th percentile, 47% of fetuses (894/1,901) had an NT between the 95th and 99th percentile and 53% (1,007/1,901) had an NT ≥ the 99th percentile. In addition, of the 43% of fetuses (814/1,901) with at least one abnormality (structural or genetic), 34% (279/814) would have been missed in the first trimester if only cell-free deoxyribonucleic acid was used for prenatal genetic screening.
-
Papers Detail Hazards of Surgical Smoke
Researchers provide more detailed definitions, offer possible solutions to minimize risk.
-
Study: IUD Counseling Can Appear Coercive
The results of a recent study revealed that providers might think they are promoting their young patients’ decision-making, but their focus on intrauterine devices and other long-acting reversible contraceptives can come across as coercive.
-
Pregnancy Risk Increases When Young Women Travel
Although most international trips, including students’ study abroad programs, were put on hold in 2020, these might resume this year after the COVID-19 vaccine reaches student populations. Reproductive health providers can help young women prepare for the contraceptive needs and uncertainties of travel. A new study revealed that young female travelers overwhelmingly say they will be abstinent during their travels, but their actual experience is the opposite.
-
New Contraceptive Patch Is a Weekly Option
Twirla, a new low-dose contraceptive patch, is effective at preventing pregnancy among American women, according to researchers. Phase III clinical trial results were favorable for efficacy, safety, and tolerability of a levonorgestrel/ethinyl estradiol transdermal delivery system. The new patch uses a progestin and contains less estrogen than prior patches.
-
Should Family Planning Clinics Volunteer to Vaccinate Patients?
One of the biggest challenges this spring will be to find enough trained medical staff and ambulatory sites to vaccinate hundreds of millions of people within a six- to seven-month time frame. Family planning centers might be lower on the priority list for vaccination because they serve a younger population.
-
Providers Can Reduce Vaccine Hesitancy Among Staff
As the COVID-19 vaccine was rolled out in the United States, many healthcare workers refused vaccination. Reproductive healthcare centers will need to obtain staff buy-in as they begin a vaccination program.
-
How Family Planning Providers Can Handle Challenges of COVID-19 Vaccine Rollout
The coronavirus vaccine rollout faces challenges from logistical supply issues and vaccine hesitancy among healthcare staff and the general public. From a reproductive health provider perspective, the big question is how to handle the rollout and overcome challenges on both the supply and demand sides.
-
Alleviate Risks if Patients Leave Without Being Seen
There is a tendency to assume that if someone left the ED, he or she probably was not that sick. That is a dangerous assumption. For all patients who leave without being seen, the nurse manager should follow up with a call within 24 hours.
-
Some Psychiatric Patients Can Bypass ED Altogether
Researchers considered protocols that bypass the ED by allowing EMS to directly transport patients to a specialized regional center for evaluation of psychiatric emergencies. The protocols are somewhat controversial.